April 29 (Reuters) - Novartis AG NOVN.S :
* ILARIS RECEIVES HEALTH CANADA APPROVAL AS FIRST OF ITS KIND TREATMENT FOR RARE, INFLAMMATORY DISORDER, ADULT-ONSET STILL'S DISEASE
April 29 (Reuters) - Novartis AG NOVN.S :
* ILARIS RECEIVES HEALTH CANADA APPROVAL AS FIRST OF ITS KIND TREATMENT FOR RARE, INFLAMMATORY DISORDER, ADULT-ONSET STILL'S DISEASE